Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
21
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 37 publications
(21 citation statements)
references
References 67 publications
0
21
0
Order By: Relevance
“…6,8,9 Decisions on when to proceed with chemotherapy for MF should involve both infectious disease specialists and hematologists/oncologists, as they must consider the progression of cutaneous infection during treatment versus the risk of death from the underlying malignancy if the treatment is delayed. 10,11 In cases such as these, multiple biopsies, fungal cultures, and MALDI-TOF may be needed to establish the etiology of the opportunistic pathogens which can present as multiple coexisting infections in a single patient.…”
Section: Discussionmentioning
confidence: 99%
“…6,8,9 Decisions on when to proceed with chemotherapy for MF should involve both infectious disease specialists and hematologists/oncologists, as they must consider the progression of cutaneous infection during treatment versus the risk of death from the underlying malignancy if the treatment is delayed. 10,11 In cases such as these, multiple biopsies, fungal cultures, and MALDI-TOF may be needed to establish the etiology of the opportunistic pathogens which can present as multiple coexisting infections in a single patient.…”
Section: Discussionmentioning
confidence: 99%
“…Bexarotene is a synthetic retinoid analogue with activity against cutaneous T-cell lymphoma and mycosis fungoides [ 34 , 35 ]. It has also been suggested to treat alopecia [ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…Widespread, advanced disease or refractory earlydisease requires systemic therapy. Biological or targeted therapies including bexarotene and interferon are first choice, with more immunosuppressive chemotherapies being reserved for refractory or rapidly progressive disease [2,3] . This patient was treated with topical potent corticostersoids and R-CDOP (Rituximab, cyclophosphamide, liposome doxorubicin, vincristine and prednisone) regimen that brought a favorable improvement in pruritus and cutaneous lesions.…”
Section: Case Presentationmentioning
confidence: 99%